Artwork

Content provided by Colabra. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Colabra or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://ro.player.fm/legal.
Player FM - Aplicație Podcast
Treceți offline cu aplicația Player FM !

Overcoming CAR-T Cell Bottlenecks - Dr. Andy Scharenberg

46:41
 
Distribuie
 

Manage episode 416329678 series 1415539
Content provided by Colabra. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Colabra or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://ro.player.fm/legal.

Immunotherapy is weaponizing the body's immune system against cancer or other disease. One of the most promising approaches is CAR-T cell therapy, yet as this technology has been implemented, it's limitations have been identified. Dr. Andy Scharenberg described the current drawbacks of CAR-T cells and how his company, Umoja, is re-engineering CAR-T cells in vivo to create more effective therapies, including approaches that can address solid tumors. Co-hosted by Donald Coon.

www.umoja-biopharma.com

  continue reading

442 episoade

Artwork
iconDistribuie
 
Manage episode 416329678 series 1415539
Content provided by Colabra. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Colabra or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://ro.player.fm/legal.

Immunotherapy is weaponizing the body's immune system against cancer or other disease. One of the most promising approaches is CAR-T cell therapy, yet as this technology has been implemented, it's limitations have been identified. Dr. Andy Scharenberg described the current drawbacks of CAR-T cells and how his company, Umoja, is re-engineering CAR-T cells in vivo to create more effective therapies, including approaches that can address solid tumors. Co-hosted by Donald Coon.

www.umoja-biopharma.com

  continue reading

442 episoade

Semua episod

×
 
Loading …

Bun venit la Player FM!

Player FM scanează web-ul pentru podcast-uri de înaltă calitate pentru a vă putea bucura acum. Este cea mai bună aplicație pentru podcast și funcționează pe Android, iPhone și pe web. Înscrieți-vă pentru a sincroniza abonamentele pe toate dispozitivele.

 

Ghid rapid de referință